Jean-Jacques Risso Selected Research

Jean-Jacques Risso Research Topics

Disease

10	Decompression Sickness (Bends) 01/2019 - 01/2012
9	Ischemic Stroke 07/2017 - 09/2008
9	Ischemia 07/2016 - 04/2008
7	Brain Ischemia (Cerebral Ischemia) 07/2016 - 04/2008
6	Inert Gas Narcosis (Nitrogen Narcosis) 03/2012 - 05/2003
4	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2016 - 06/2009
4	Stroke (Strokes) 01/2016 - 04/2010
4	Stupor 01/2014 - 03/2003
3	Wounds and Injuries (Trauma) 01/2018 - 01/2013
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2016 - 04/2010
2	High Pressure Neurological Syndrome (High Pressure Nervous Syndrome) 04/2016 - 02/2009
2	Hypothermia 01/2016 - 06/2009
2	Transient Ischemic Attack 09/2008 - 04/2008
1	Infarction (Infarctions) 07/2016
1	Edema (Dropsy) 04/2016
1	Seizures (Absence Seizure) 02/2014
1	Asphyxia (Suffocation) 01/2013
1	Inflammation (Inflammations) 01/2012
1	Hyperoxia 04/2011
1	Gliosis 02/2010
1	Cicatrix (Scar) 12/2009
1	Status Epilepticus (Complex Partial Status Epilepticus) 06/2009
1	Hypoxia (Hypoxemia) 06/2009
1	Epilepsy (Aura) 02/2009
1	Neuroblastoma 12/2008
1	Amnesia (Dissociative Amnesia) 01/2007
1	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2004
1	Hyperkinesis 05/2003
1	Cognitive Dysfunction 05/2003

Drug/Important Bio-Agent (IBA)

10	Oxygen (Dioxygen)IBA 07/2017 - 12/2004
7	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2016 - 04/2010
7	Neuroprotective AgentsIBA 01/2016 - 04/2008
7	NitrogenIBA 01/2014 - 03/2003
5	XenonIBA 01/2016 - 04/2008
5	ArgonIBA 01/2016 - 03/2003
5	Dopamine (Intropin)FDA LinkGeneric 03/2012 - 05/2003
5	N-Methylaspartate (NMDA)IBA 03/2012 - 04/2008
4	Glucose (Dextrose)FDA LinkGeneric 07/2017 - 04/2011
4	Fluoxetine (Prozac)FDA LinkGeneric 01/2017 - 01/2012
4	Noble Gases (Rare Gases)IBA 01/2016 - 05/2003
4	HeliumIBA 01/2016 - 02/2009
4	Nitrous Oxide (Laughing Gas)IBA 01/2014 - 03/2003
3	Antidepressive Agents (Antidepressants)IBA 01/2016 - 01/2012
3	Glutamic Acid (Glutamate)FDA Link 05/2010 - 05/2009
3	Matrix Metalloproteinases (MMPs)IBA 02/2010 - 12/2008
3	Neurotransmitter Agents (Neurotransmitter)IBA 09/2008 - 05/2003
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 07/2017 - 07/2016
2	Narcotics (Narcotic Analgesics)IBA 04/2016 - 05/2003
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2016 - 01/2013
2	potassium channel protein TREK-1IBA 01/2016 - 04/2012
2	gabazineIBA 03/2012 - 03/2003
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Minocycline (Cyclops)FDA LinkGeneric 01/2019
1	Tirofiban (Aggrastat)FDA Link 01/2018
1	Mitochondrial DNA (mtDNA)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 01/2018
1	CytokinesIBA 12/2015
1	Interleukin-10 (Interleukin 10)IBA 12/2015
1	Potassium Channels (Potassium Channel)IBA 04/2012
1	Interleukin-6 (Interleukin 6)IBA 01/2012
1	NeurotoxinsIBA 04/2011
1	CalciumIBA 04/2011
1	Serine Proteases (Serine Protease)IBA 04/2010
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2009
1	Pilocarpine (Ocusert)FDA LinkGeneric 06/2009
1	Anesthetics (Anesthetic Agents)IBA 06/2009
1	Amino Acids FDA Link 05/2009
1	Tissue Inhibitor of Metalloproteinase-1IBA 12/2008
1	Proteins (Proteins, Gene)FDA Link 01/2007
1	General AnestheticsIBA 01/2007
1	Ion Channels (Ion Channel)IBA 01/2007
1	GABA AntagonistsIBA 03/2003
1	gamma-Aminobutyric Acid (GABA)IBA 03/2003
1	Flumazenil (Romazicon)FDA LinkGeneric 03/2003
1	GABA-A Receptors (GABA(A) Receptor)IBA 03/2003
1	2-hydroxysaclofenIBA 03/2003
1	GABA-A Receptor AntagonistsIBA 03/2003
1	GABA-B Receptor AntagonistsIBA 03/2003

Therapy/Procedure

4	Therapeutics 01/2016 - 04/2010
1	Decompression 01/2013
1	Anesthesia 01/2007
1	Hypnosis (Mesmerism) 01/2007